These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7005345)

  • 1. Endotoxin requirement for macrophage activation by lymphokines in a rapid microcytotoxicity assay.
    Taramelli D; Holden HT; Varesio L
    J Immunol Methods; 1980; 37(3-4):225-32. PubMed ID: 7005345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphokines inhibit macrophage RNA synthesis.
    Varesio L; Issaq HJ; Kowal R; Bonvini E; Taramelli D
    Cell Immunol; 1984 Mar; 84(1):51-64. PubMed ID: 6199124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of the tumoricidal function of activated macrophages by bacterial endotoxin and mammalian macrophage activation factor (s).
    Hibbs JB; Weinberg JB; Chapman HA
    Adv Exp Med Biol; 1979; 121B():433-53. PubMed ID: 232620
    [No Abstract]   [Full Text] [Related]  

  • 4. Microassay for photometric quantitation of macrophage mediated tumor cytotoxicity using an automated densitometer.
    Leu RW; Herriott MJ
    J Immunol Methods; 1984 Feb; 67(1):63-72. PubMed ID: 6366067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of murine macrophages. I. Different pattern of activation by poly I:C than by lymphokine or LPS.
    Taramelli D; Varesio L
    J Immunol; 1981 Jul; 127(1):58-63. PubMed ID: 6787132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro induction of tumoricidal and suppressor macrophages by lymphokines: possible feedback regulation.
    Taramelli D; Holden HT; Varesio L
    J Immunol; 1981 Jun; 126(6):2123-8. PubMed ID: 6453155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A convenient and sensitive cytotoxicity assay for macrophage activating factor.
    Roberts WK; Vasil A
    J Immunol Methods; 1982 Nov; 54(3):371-7. PubMed ID: 6757329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro studies on the tumour cytotoxicity of normal, stimulated and immunologically activated mouse macrophages.
    Hansen JG; Bennedsen J; Rhodes JM; Larsen SO
    Acta Pathol Microbiol Immunol Scand C; 1982 Feb; 90(1):27-32. PubMed ID: 7080837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of mouse macrophages for tumor cell killing. I. Quantitative analysis of interactions between lymphokine and lipopolysaccharide.
    Pace JL; Russell SW
    J Immunol; 1981 May; 126(5):1863-7. PubMed ID: 7217671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The capacity of activated murine macrophages for augmented binding of neoplastic cells: analysis of induction by lymphokine containing MAF and kinetics of the reaction.
    Marino PA; Adams DO
    J Immunol; 1982 Jun; 128(6):2816-23. PubMed ID: 6804569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance of macrophages from C3H/HeJ mice to the in vitro cytotoxic effects of endotoxin.
    Glode LM; Jacques A; Mergenhagen SE; Rosenstreich DL
    J Immunol; 1977 Jul; 119(1):162-6. PubMed ID: 326955
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on macrophage-activating factor (MAF) in antitumor immune responses. I. Tumor-specific Lyt-1+2- T cells are required for producing MAF able to generate cytolytic as well as cytostatic macrophages.
    Nakajima H; Fujiwara H; Takai Y; Izumi Y; Sano S; Tsuchida T; Hamaoka T
    J Immunol; 1985 Sep; 135(3):2199-205. PubMed ID: 3894520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for a gamma-interferon receptor that regulates macrophage tumoricidal activity.
    Celada A; Gray PW; Rinderknecht E; Schreiber RD
    J Exp Med; 1984 Jul; 160(1):55-74. PubMed ID: 6330272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of tumoricidal properties in mouse macrophages by lymphokines encapsulated in liposomes.
    Poste G; Kirsh R; Fogler WE; Fidler IJ
    Cancer Res; 1979 Mar; 39(3):881-92. PubMed ID: 427777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro assay of spontaneous cytotoxicity by human monocytes and macrophages against tumor cells.
    Mukherji B
    J Immunol Methods; 1980; 37(3-4):233-47. PubMed ID: 7451996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ganglioside expression in macrophages from endotoxin responder and nonresponder mice.
    Yohe HC; Ryan JL
    J Immunol; 1986 Dec; 137(12):3921-7. PubMed ID: 3537127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of C3 as a marker of lymphokine-mediated macrophage activation.
    Koestler TP; Kirsh R; Kline T; Rieman D; Greig R; Poste G
    Cell Immunol; 1984 Aug; 87(1):1-14. PubMed ID: 6378389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-induced enhancement of macrophage-mediated tumor cytolysis and its difference from activation by lymphokines.
    Boraschi D; Tagliabue A
    Eur J Immunol; 1981 Feb; 11(2):110-4. PubMed ID: 6163639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage sensitivity to endotoxin: genetic control by a single codominant gene.
    Rosenstreich DL; Vogel SN; Jacques AR; Wahl LM; Oppenheim JJ
    J Immunol; 1978 Nov; 121(5):1664-70. PubMed ID: 101590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The activation of tumoricidal properties in macrophages of endotoxin responder and nonresponder mice by liposome-encapsulated immunomodulators.
    Fogler WE; Talmadge JE; Fidler IJ
    J Reticuloendothel Soc; 1983 Mar; 33(3):165-74. PubMed ID: 6834360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.